Key Concepts in Pregnancy of Unknown Location: Identifying Ectopic Pregnancy and Providing Patient-Centered Care
Corresponding Author
Loren Fields WHNP-BC, MSN,
Address correspondence to Loren Fields, WHNP-BC, MSN, Yale University West Campus, Yale School of Nursing Bldg, PO Box 27399, West Haven, CT 06516-0927. E-mail: [email protected]Search for more papers by this authorAlison Hathaway WHNP-BC, MSN
Search for more papers by this authorCorresponding Author
Loren Fields WHNP-BC, MSN,
Address correspondence to Loren Fields, WHNP-BC, MSN, Yale University West Campus, Yale School of Nursing Bldg, PO Box 27399, West Haven, CT 06516-0927. E-mail: [email protected]Search for more papers by this authorAlison Hathaway WHNP-BC, MSN
Search for more papers by this authorAbstract
Pregnancy of unknown location (PUL) is a descriptive term for when a woman with a positive pregnancy test has a transvaginal ultrasound that cannot determine the site of the pregnancy. While the majority of women with PUL are subsequently diagnosed with a spontaneous abortion or viable intrauterine pregnancy, 7% to 20% of these women have an ectopic pregnancy. The potential for morbidity and mortality related to an ectopic pregnancy means that considerable care is necessary in the evaluation and management of women with PUL. In some cases, the location of the pregnancy is never determined and the PUL is categorized as resolving or persisting. Evidence suggests expectant management is a safe and effective approach for most women with PUL and should be the mainstay of care. However, in the case of persisting PUL, continued concern for ectopic pregnancy remains. Strategies for deciding when to intervene when a woman has a PUL are reviewed. A variety of clinical tools, including serum beta human chorionic gonadotropin (β-hCG), repeat ultrasonography, dilation and curettage (D&C), and empiric methotrexate therapy are discussed. Finally, a proposal is made that women with persisting PUL can be presented with the option of choosing expectant management, diagnostic D&C, or empiric methotrexate treatment.
REFERENCES
- 1Barnhart K, van Mello NM, Bourne T, et al. Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. Fertil Steril. 2011; 95(3): 857-866.
- 2Kirk E, Bourne T. Predicting outcomes in pregnancies of unknown location. Womens Health (Lond Engl). 2008; 4(5): 491-499.
- 3Van Calster B, Abdallah Y, Guha S, et al. Rationalizing the management of pregnancies of unknown location: temporal and external validation of a risk prediction model on 1962 pregnancies. Hum Reprod. 2013; 28(3): 609-616.
- 4Reid S, Condous G. Is there a need to definitively diagnose the location of a pregnancy of unknown location? The case for “no.” Fertil Steril. 2012; 98(5): 1085-1090.
- 5Mavrelos D, Memtsa M, Helmy S, Derdelis G, Jauniaux E, Jurkovic D. Beta-hCG resolution times during expectant management of tubal ectopic pregnancies. BMC Womens Health. 2015; 15: 43.
- 6Condous G, Kirk E, Van Calster B, Van Huffel S, Timmerman D, Bourne T. Failing pregnancies of unknown location: a prospective evaluation of the human chorionic gonadotrophin ratio. BJOG. 2006; 113(5): 521-527.
- 7Kirk E, Condous G, Van Calster B, Van Huffel S, Timmerman D, Bourne T. Rationalizing the follow-up of pregnancies of unknown location. Hum Reprod. 2007; 22(6): 1744-1750.
- 8Kirk E, Bottomley C, Bourne T. Diagnosing ectopic pregnancy and current concepts in the management of pregnancy of unknown location. Hum Reprod Update. 2014; 20(2): 250-261.
- 9 Committee on Practice Bulletins-Gynecology. The American College of Obstetricians and Gynecologists practice bulletin no. 150. Early pregnancy loss. Obstet Gynecol. 2015; 125(5): 1258-1267.
- 10Condous G, Okaro E, Khalid A, Bourne T. Do we need to follow up complete miscarriages with serum human chorionic gonadotrophin levels? BJOG. 2005; 112(6): 827-829.
- 11Kirk E. Ultrasound in the diagnosis of ectopic pregnancy. Clin Obstet Gynecol. 2012; 55(2): 395-401.
- 12Kirk E, Papageorghiou AT, Condous G, Tan L, Bora S, Bourne T. The diagnostic effectiveness of an initial transvaginal scan in detecting ectopic pregnancy. Hum Reprod. 2007; 22(11): 2824-2828.
- 13Kirk E, Daemen A, Papageorghiou AT, et al. Why are some ectopic pregnancies characterized as pregnancies of unknown location at the initial transvaginal ultrasound examination? Acta Obstet Gynecol Scand. 2008; 87(11): 1150-1154.
- 14Benson CB, Doubilet PM, Peters HE, Frates MC. Intrauterine fluid with ectopic pregnancy: a reappraisal. J Ultrasound Med. 2013; 32(3): 389-393.
- 15 American College of Nurse Midwives. Midwives’ Performance of Ultrasound in Clinical Practice. Silver Spring, MD: American College of Nurse Midwives; 2012.
- 16 Association of Women's Health, Obstetric and Neonatal Nurses. Ultrasound Examinations Performed by Nurses in Obstetric, Gynecologic, and Reproductive Medicine Settings: Clinical Competencies and Education Guide. 3rd ed. Washington, DC: Association of Women's Health, Obstetric and Neonatal Nurses; 2010.
- 17Verhaegen J, Gallos ID, van Mello NM, et al. Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies. BMJ. 2012; 345: e6077.
- 18 American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 94: medical management of ectopic pregnancy. Obstet Gynecol. 2008; 111(6): 1479-1485.
- 19Seeber BE. What serial hCG can tell you, and cannot tell you, about an early pregnancy. Fertil Steril. 2012; 98(5): 1074-1077.
- 20 Practice Committee of American Society for Reproductive Medicine. Medical treatment of ectopic pregnancy: a committee opinion. Fertil Steril. 2013; 100(3): 638-644.
- 21Doubilet PM, Benson CB. Further evidence against the reliability of the human chorionic gonadotropin discriminatory level. J Ultrasound Med. 2011; 30(12): 1637-1642.
- 22Ko JK, Cheung VY. Time to revisit the human chorionic gonadotropin discriminatory level in the management of pregnancy of unknown location. J Ultrasound Med. 2014; 33(3): 465-471.
- 23Kadar N, Freedman M, Zacher M. Further observations on the doubling time of human chorionic gonadotropin in early asymptomatic pregnancies. Fertil Steril. 1990; 54(5): 783-787.
- 24Barnhart KT, Sammel MD, Rinaudo PF, Zhou L, Hummel AC, Guo W. Symptomatic patients with an early viable intrauterine pregnancy: hCG curves redefined. Obstet Gynecol. 2004; 104(1): 50-55.
- 25Zee J, Sammel MD, Chung K, Takacs P, Bourne T, Barnhart KT. Ectopic pregnancy prediction in women with a pregnancy of unknown location: data beyond 48 h are necessary. Hum Reprod. 2014; 29(3): 441-447.
- 26Barnhart K, Sammel MD, Chung K, Zhou L, Hummel AC, Guo W. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve. Obstet Gynecol. 2004; 104(5 Pt 1): 975-981.
- 27Barnhart KT, Sammel MD, Appleby D, et al. Does a prediction model for pregnancy of unknown location developed in the UK validate on a US population?. Hum Reprod. 2010; 25(10): 2434-2440.
- 28Silva C, Sammel MD, Zhou L, Gracia C, Hummel AC, Barnhart K. Human chorionic gonadotropin profile for women with ectopic pregnancy. Obstet Gynecol. 2006; 107(3): 605-610.
- 29Dillon KE, Sioulas VD, Sammel MD, et al. How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity. Fertil Steril. 2012; 98(4): 911-916.
- 30Chung K, Chandavarkar U, Opper N, Barnhart K. Reevaluating the role of dilation and curettage in the diagnosis of pregnancy of unknown location. Fertil Steril. 2011; 96(3): 659-662.
- 31Rubal L, Chung K. Do you need to definitively diagnose the location of a pregnancy of unknown location? The case for “yes.” Fertil Steril. 2012; 98(5): 1078-1084.
- 32Bryant AG, Regan E, Stuart G. An overview of medical abortion for clinical practice. Obstet Gynecol Surv. 2014; 69(1): 39-45.
- 33Kulier R, Kapp N, Gulmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2011; 11.
- 34Moreno-Ruiz NL, Borgatta L, Yanow S, Kapp N, Wiebe ER, Winikoff B. Alternatives to mifepristone for early medical abortion. Int J Gynaecol Obstet. 2007; 96(3): 212-218.
- 35Wu J, Ludlow JP, De Vries B, Black K, Beale P. Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success. Aust N Z J Obstet Gynaecol. 2014; 54(5): 469-474.
- 36van Mello NM, Mol F, Verhoeve HR, et al. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison. Hum Reprod. 2013; 28(1): 60-67.
- 37van Mello NM, Mol F, Hajenius P, et al. Randomized comparison of health-related quality of life in women with ectopic pregnancy or pregnancy of unknown location treated with systemic methotrexate or expectant management. Eur J Obstet Gynecol Reprod Biol. 2015; 192: 1-5.
- 38Svirsky R, Rozovski U, Vaknin Z, Pansky M, Schneider D, Halperin R. The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy. Reprod Toxicol. 2009; 27(1): 85-87.